Pancreatic Cancer Research

ResearcherKumamoto Regional Medical CenterNo recent work listed

Kota Arima

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103764289. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2016: 3 papers · 2017: none · 2018: 4 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 13

  1. Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancer. Co-author DOI 10.1111/cas.15495↗
  2. Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.09.007↗
  3. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients underg… Co-author DOI 10.1007/s00595-019-01866-x↗
  4. Efficacy of Staging Laparoscopy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.14037↗
  5. Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer. First author DOI 10.1007/s00535-018-01535-9↗
  6. PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis. Co-author DOI 10.1111/cas.13874↗
  7. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2017.08.016↗
  8. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer. Co-author DOI 10.1111/cas.13467↗
  9. Multiple Primary Cancers in Patients with Pancreatic Cancer. Co-author DOI 10.1177/000313481808401205↗
  10. Cystic gastric metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-018-0443-2↗
  11. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer. Co-author DOI 10.1007/s00595-015-1238-8↗
  12. The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases. Co-author DOI 10.1007/s10147-016-0975-z↗
  13. Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/mpa.0000000000000624↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akira Chikamoto · 10 shared papers, 2016–2020 · strength 0.68
  2. Yuki Kitano · 8 shared papers, 2016–2021 · strength 0.62
  3. Daisuke Hashimoto · 9 shared papers, 2016–2020 · strength 0.61
  4. Tatsunori Miyata · 7 shared papers, 2018–2021 · strength 0.57
  5. Katsunori Imai · 7 shared papers, 2016–2021 · strength 0.51
  6. Hirohisa Okabe · 7 shared papers, 2016–2020 · strength 0.49
  7. Hideo Baba · 6 shared papers, 2016–2022 · strength 0.45
  8. Shigeki Nakagawa · 6 shared papers, 2018–2019 · strength 0.43
  9. Takatsugu Ishimoto · 5 shared papers, 2018–2022 · strength 0.42
  10. Takanobu Yamao · 5 shared papers, 2018–2020 · strength 0.41
  11. Masayo Tsukamoto · 5 shared papers, 2018–2020 · strength 0.37
  12. Rumi Itoyama · 4 shared papers, 2018–2022 · strength 0.36
  13. Kensuke Yamamura · 5 shared papers, 2016–2020 · strength 0.36
  14. Naoki Umezaki · 4 shared papers, 2018–2020 · strength 0.31
  15. Luke Bu · 3 shared papers, 2018–2022 · strength 0.27
  16. Tomoyuki Uchihara · 3 shared papers, 2018–2022 · strength 0.27
  17. Hiromitsu Hayashi · 3 shared papers, 2016–2021 · strength 0.24
  18. Hideo Baba · 3 shared papers, 2016–2020 · strength 0.22
  19. Takayoshi Kaida · 4 shared papers, 2016–2018 · strength 0.22
  20. Masahiko Hirota · 3 shared papers, 2016–2019 · strength 0.21
  21. Hidetoshi Nitta · 3 shared papers, 2016–2020 · strength 0.21
  22. Fumimasa Kitamura · 2 shared papers, 2021–2022 · strength 0.21
  23. Yosuke Nakao · 2 shared papers, 2020–2021 · strength 0.18
  24. Hideo Baba · 2 shared papers, 2019–2021 · strength 0.17
  25. Hideo Baba · 2 shared papers, 2018 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.